01 2Procos SpA
01 1N-METHYL AMISULPRIDE
02 1N-methyl-Amisulpride
01 2Italy
NDC Package Code : 46016-2220
Start Marketing Date : 2023-04-04
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 46016-1390
Start Marketing Date : 2023-02-07
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A N-Methyl Amisulpride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of N-Methyl Amisulpride, including repackagers and relabelers. The FDA regulates N-Methyl Amisulpride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. N-Methyl Amisulpride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A N-Methyl Amisulpride supplier is an individual or a company that provides N-Methyl Amisulpride active pharmaceutical ingredient (API) or N-Methyl Amisulpride finished formulations upon request. The N-Methyl Amisulpride suppliers may include N-Methyl Amisulpride API manufacturers, exporters, distributors and traders.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing N-Methyl Amisulpride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for N-Methyl Amisulpride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture N-Methyl Amisulpride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain N-Methyl Amisulpride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a N-Methyl Amisulpride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of N-Methyl Amisulpride suppliers with NDC on PharmaCompass.
We have 1 companies offering N-Methyl Amisulpride
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
